Modified colorectal CA screening score improves risk prediction

June 19, 2017

(HealthDay)—A modified colorectal cancer screening score improves risk prediction of advanced neoplasia, according to a study published online May 31 in the Journal of Gastroenterology and Hepatology.

Joseph J.Y. Sung, M.D., Ph.D., from the Chinese University of Hong Kong, and colleagues validated a modified risk algorithm based on the Asia Pacific Colorectal Screening (APCS) score for of advanced neoplasia. A random sample of 3,829 Chinese asymptomatic screening participants undergoing a colonoscopy acted as the derivation cohort; performance of the score was assessed in 1,915 subjects in a validation cohort.

The researchers found that the prevalence of advanced neoplasia was 5.4 and 6.0 percent in the derivation and validation cohorts, respectively. In multivariate regression analysis, old age, male gender, family history of , smoking, and (BMI) were significant predictors. Better predictive capability and lower number needed to screen were seen for a BMI cut-off of >23 kg/m² versus >25 kg/m². Within the validation cohort, 8.4, 57.4, and 34.2 percent were categorized as average risk, moderate risk, and high risk, respectively, with corresponding prevalence of advanced neoplasia of 3.8, 4.3, and 9.3 percent. Compared with using predictors of APCS alone, the c-statistics of the modified score had better discriminatory capacity (c-statistics, 0.65 versus 0.60).

"Incorporating BMI into the predictors of APCS score was found to improve of advanced neoplasia and reduce colonoscopy resources," the authors write.

Explore further: Index stratifies risk for advanced colorectal neoplasia

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Index stratifies risk for advanced colorectal neoplasia

August 12, 2015
(HealthDay)—A scoring system can stratify risk for advanced colorectal neoplasia in asymptomatic adults, according to a study published online Aug. 11 in the Annals of Internal Medicine.

Review: weak power in most CRC neoplasia risk prediction models

October 14, 2014
(HealthDay)—Most colorectal neoplasia risk prediction models have weak discriminatory power, according to a review published in the October issue of Clinical Gastroenterology and Hepatology.

Factors ID'd for CRC risk stratification with positive FIT

September 12, 2014
(HealthDay)—Fecal hemoglobin concentration, sex, and age can be used to classify the risk of advanced colorectal neoplasia among individuals with positive results from fecal immunochemical tests (FITs), according to a study ...

New risk score for colorectal cancer, advanced polyps could guide selection of screening test for patients, physicians

September 10, 2015
Researchers at the Regenstrief Institute and the Indiana University School of Medicine have developed a new risk assessment scoring system that could help physicians judge which patients can forgo invasive colonoscopy testing ...

Nomogram predicts survival for adults undergoing CAC scoring

June 15, 2017
(HealthDay)—A simple-to-use nomogram can predict five-, 10-, and 15-year survival among adults undergoing coronary artery calcium scoring (CACS), according to a study published online June 14 in JACC: Cardiovascular Imaging.

Model including CRC risk alleles ups risk discrimination

June 4, 2015
(HealthDay)—Incorporation of a genetic risk score can improve the accuracy of colorectal cancer (CRC) risk determination, according to a study published in the June issue of Gastroenterology.

Recommended for you

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.